After therapy, women are followed every three months with a careful general physical examination, pelvic examination and Pap smear.
• A chest x-ray or an abdominal or pelvic CT scan may be obtained if symptoms warrant.
• If the serum CEA and/or AFP were elevated before therapy, they can be followed to detect recurrent disease.